|
Thursday, February 7, 2008
|
| 15:00-18:30 |
Registration |
| 18:30 |
Get together reception |
|
Friday, February 8, 2008
|
| 8:00-18:00 |
Registration |
8:00-08:20 Opening ceremony |
| 8:00 |
Welcome address
Prof. Talma Rosenthal, Conference Co-Chair, Israel
Dr. Agnes Horvath, Minister for Health, Hungary |
|
8:20 - 10:10 Plenary Session 1
|
| |
Chairs: Karl H. Rahn, Germany
Sverre E. Kjeldsen, Norway |
| 8:20 |
Fixed Drug Combinations in Antihypertensive Therapy: Historical Evolution
Irene Gavras, USA |
| 8:50 |
International Antipathy to Fixed-Dose Combinations for Hypertension - Time to Change Closed Minds
Gareth Beevers, UK |
| 9:20 |
Combination Treatment in the Light of the ESH-ESC 2007 Guidelines Serap Erdine, Turkey
|
| 9:50 |
Intensified Combination Treatment of Hypertension: Predictors of Blood Pressure Response in the ACCOMPLISH Study
Sverre E Kjeldsen, Norway |
| |
|
| 10:10-10:30 |
Coffee Break, Exhibition and Posters |
| |
|
| 10:30-12:30 Plenary Session 2 |
| |
Chairs: Hans R. Brunner, Switzerland
Reuven Zimlichman, Israel |
| 10:30 |
Combination Treatment and Cardiovascular Structure
A.M. Heagerty, UK |
| 11:00 |
Combination Treatment and Hypertensive Heart Disease
Athanasios Manolis, Greece |
| 11:30 |
Fixed Combination in Hypertension and Dyslipidemia (Caduet)
Renata Cifkova, Czech Republic |
| 12:00 |
Global Benefits of Lipid Lowering and Blood Pressure Lowering in Hypertension: Have We Underestimated the Real Benefit?
PS Sever, UK |
| |
|
| 12:30-14:00 |
Lunch Break |
| |
|
| 14:00-15:30 |
Are We Treating Blood Pressure or Patients with Hypertension?
Chair: Csaba Farsang, Hungary |
| |
 Satellite Symposium sponsored by Pfizer
Are We Treating Blood Pressure or Patients with Hypertension?
Bryan Williams UK
Before Clinical Outcomes: Early Endothelial Damage
Preston Mason USA
Beyond the Physician’s Office: Role of the Patient in Effective Therapy
Leif Erhardt Sweden
Panel Discussion
Faculty |
| |
|
| 15:30-16:00 |
Coffee Break, Exhibition and Posters
|
| |
|
| 16:00-17:30 |
ARBs: Towards an optimal treatment foundation for hypertension and cardiovascular protection
Chair: Csaba Farsang, Hungary |
|
Satellite Symposium sponsored by Boehringer Ingelheim 
|
| |
Understanding the Cardiovascular Protection Mechanism of ARBs Alone and in Combination
Ulrich Kintscher, Germany
ARBs in Hypertension: Are All the Same?
Csaba Farsang, Hungary
Albuminuria: Marker of Risk, Target of Therapy
George Bakris, USA
ONTARGET: The Ultimate Trial in CV Protection
Haralambos Gavras, USA
|
| |
|
| 17:30-18:00 |
Winter Party with Gluhwine and Chestnuts |
| |
|
| 18:00-19:30 Plenary Session 3 |
| |
Chairs: Krzysztof Narkiewicz, Poland
Michael Bursztyn, Israel |
| 18:00 |
Renin Inhibitor-Angiotensin II Receptor Antagonist Combinations Suzanne Oparil, USA |
| 18:30 |
Is Reduction of Sodium Intake Still Advisable in Combination Therapy Albert Mimran, France |
| 19:00 |
The ADVANCE Trial: a Simple Therapeutic Strategy Providing Major Cardio-Renal Benefits in Patients with Type II Diabetes
Bernard Waeber, Switzerland |
| |
|
Saturday, February 9, 2008 |
8:30-10:00 Plenary Session 4 |
| 8:30 |
Early Vascular Ageing (EVA-Syndrome) - Background and Prevention by Effective Risk Factor Control with Combination Treatment
Peter M Nilsson, Sweden |
| 9:00 |
Peripheral Artery Diseases (PAD): Indication of Excellence for Drug Combinations
Denis Clement, Belgium |
| 9:30 |
The Future of Intervention Treatment in Hypertension
Giuseppe Mancia, Italy |
| |
|
| 10:00-10:30 |
Coffee Break, Exhibition and Posters
|
| |
|
| 10:30-12:30 Plenary Session 5 |
| |
Chairs: Haralambos Gavras, USA
Eli J. Holtzman, Israel |
| 10:30 |
Fixed Drug Combination In Hypertension And Hyperlipidaemia In The Developing World
Yackoob Seedat, South Africa |
| 11:00 |
 Combination Therapy and the Kidney
Herman Haller, Germany - sponsored by Recordati |
| 11:30 |
The Polypill Paradigm: Merging the Clinical and Public Health Perspectives. Moving Toward Treating Absolute Cardiovascular Risk instead of only Risk Factors
Richard Grimm, USA |
| 12:00 |
Antihypertensive Therapy - Is Lower Always Better?
Franz H. Messerli, USA |
| |
|
| 12:30-14:00 |
Lunch Break
|
| |
|
| 14:00-15:30 |
Parallel Satellites |
| |
|
| 14:00-15:30 |
Joining Forces - ARBs and CCBs in Fixed Dose Combinations
Chair: H Brunner |
| |
 Satellite Symposium sponsored by Daiichi-Sankyo
Hypertension: The Unmet Need
R. Kreutz, Germany
Making the Right Choices
A. de la Sierra, Spain
ARB plus CCB: Clinical Evidence
F. Messerli, USA
Summary and Closing Remarks
H. Brunner, Switzerland |
| |
|
| 14:00-15:30 |
Create Fixed Combination Drug
Chairs: Csaba Farsang, Hungary
Gyorgy Abraham, Hungary |
| |
 Satellite Symposium sponsored by Gedeon Richter
Importance of Drug Combination in the Treatment of Hypertension: Emphasis on Lisinopril+Amlodipine Fixed Combination
Csaba Farsang, Hungary
Lisinopril and Amlodipine: More than Just Blood Pressure Control
Gyorgy Abraham, Hungary |
| |
|
| 15:30-16:00 |
Coffee Break, Exhibition and Posters
|
| |
|
| 16:00-17:30 Plenary Session 6 |
| |
Chairs: George Bakris, USA
Esther Paran, Israel |
| 16:00 |
Optimizing BP Management in the CKD Patient
George Bakris, USA |
| 16:30 |
Debate - Should we Start Directly with Fixed Combination, or Should it Be the Second Stage of Treatment?
Pros: Peter S. Sever, UK
Cons: Giuseppe Mancia, Italy
Discussion |
| |
|
|
20:00-23:00
|
Gala Dinner
|
|
|
|
Sunday, February 10, 2008 |
08:30-10:15 Plenary session 7 |
| |
Chairs: Franz H. Messerli, USA
Joshua Weisgarten, Israel |
| 8:30 |
Effects of a Low-Dose Combination of Manidipine and Lisinopril (vs.full-dose
Manidipine, Amlodipine or Telmisartan) on Multiple Inflammatory and
Prothrombotic Markers in Non-Diabetic Hypertensive Patients with Metabolic
Syndrome (The MARCADOR Study)
Francisco J. Martinez-Martin, Spain |
| 9:00 |
How to Combine Antihypertensive Drugs
Csaba Farsang, Hungary |
| 9:30 |
Effect of Ezetimibe on Lipoprotein Subfraction Concentrations: The Role of Atorvastatin Pretreatment
Vasilis Tsimihodimos, Greece |
| 9:45 |
A Comparison of Cardiovascular Risk Reduction With Single-Pill Amlodipine/ Atorvastatin Between an Ethnically Diverse Population and Homogenous Populations: A Post-hoc Comparison of Results From GEMINI AALA, JEWEL 1, and JEWEL 2
Serap Erdine, Turkey |
| 10:00 |
Vascular Pleiosynergy – Does It Really Work?
Albert Csaszar, Hungary |
| |
|
| 10:15:10:45 |
Coffee break, exhibition and poster visit |
| |
|
| 10:30-12:00 Plenary session 8 |
| |
Chairs: Irene Gavras, USA
Yackoob Seedat, South Africa |
| 10:30 |
Fixed Combinations Overcome Problems of Polypharmacy in the Elderly Talma Rosenthal, Israel |
| 11:00 |
ACEI and ARbs Fixed Combination - Pros and Cons
Antonio Salveti, Italy
Joel Menard, France
Discussion |
| 12:00-12:30 |
Closing Remarks
Yackoob Seedat, South Africa |
